1
|
Romina SI, Benjamín DLCT, Mara MM, Ester GG. Quantification of rifampicin loaded into inhaled polymeric nanoparticles by reversed phase high-performance liquid chromatography in pulmonary nonphagocytic cellular uptake. ANALYTICAL METHODS : ADVANCING METHODS AND APPLICATIONS 2024; 16:1908-1915. [PMID: 38494905 DOI: 10.1039/d4ay00234b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
Rifampicin is an antibiotic effective against both Gram-negative and Gram-positive bacteria and is commonly used as a first-line treatment for tuberculosis caused by Mycobacterium tuberculosis. In this study, a reversed-phase high-performance liquid chromatography method was developed and validated to assess rifampicin, either free or combined with ascorbic acid, loaded into chitosan/Tween 80-coated alginate nanoparticles. The method utilized a reversed-phase C18 Restek column with specific chromatographic conditions: a mobile phase of 60 : 40 ratios of methanol/buffer phosphate (pH 7.0), at a flow rate of 0.8 mL min-1, and an injection volume of 15 μL. rifampicin and the internal standard (rifamycin) had retention times of 4.0 and 2.5 min, respectively, and were detected at 334 nm. The method demonstrated the stability of stored samples after freezing-thawing cycles and specificity for rifampicin, even in the presence of degradation products from stress conditions. The high-performance liquid chromatography method was found to be specific, precise, robust, and sensitive. Results indicated that rifampicin accumulation and uptake kinetics varied based on cell type, formulation (free or loaded in nanoparticles), rifampicin concentration, and incubation time. Confocal fluorescence microscopy images supported these findings, showing isothiocyanate fluorescein nanoparticles distribution in different intracellular regions depending on the cell type used. The societal impact of this research lies in its potential to advance the treatment of respiratory infectious diseases, such as tuberculosis, through the development of more effective and specific drug delivery methods. By optimizing the way drugs, particularly rifampicin in this case, interact with lung cells, we aim to achieve greater treatment efficacy and alleviate the overall burden of disease. Furthermore, our study offers novel insights into the intracellular behavior of rifampin from polymeric nanoparticles, paving the way for personalized medicine approaches in the treatment of respiratory infections. This dual focus on social impact and innovation underscores our commitment to improving global health outcomes and addressing pressing public health challenges.
Collapse
Affiliation(s)
- Scolari Ivana Romina
- Unidad de Investigación Y Desarrollo en Tecnología Farmacéutica (UNITEFA - CONICET), Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, X5000HUA, Argentina.
| | - De La Cruz-Thea Benjamín
- Instituto de Investigación Médica Mercedes y Martín Ferreyra, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Córdoba (INIMEC-CONICET-UNC), Córdoba, Argentina
| | - Musri Melina Mara
- Instituto de Investigación Médica Mercedes y Martín Ferreyra, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Córdoba (INIMEC-CONICET-UNC), Córdoba, Argentina
- Facultad de Ciencias Exactas Físicas y Naturales, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Granero Gladys Ester
- Unidad de Investigación Y Desarrollo en Tecnología Farmacéutica (UNITEFA - CONICET), Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, X5000HUA, Argentina.
| |
Collapse
|
2
|
Karaźniewicz-Łada M, Kosicka-Noworzyń K, Rao P, Modi N, Xie YL, Heysell SK, Kagan L. New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS. J Pharm Biomed Anal 2023; 235:115650. [PMID: 37597382 PMCID: PMC10566301 DOI: 10.1016/j.jpba.2023.115650] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Revised: 08/14/2023] [Accepted: 08/14/2023] [Indexed: 08/21/2023]
Abstract
Successful tuberculosis (TB) therapy requires achieving sufficient exposure to multiple drugs. Limited stability of several first-line anti-TB drugs might compromise reliable therapeutic drug monitoring (TDM). We developed and validated a sensitive and selective UPLC-MS/MS method for simultaneous quantification of isoniazid (INH), pyrazinamide (PZA), rifampicin (RIF), its metabolite 25-desacetylrifampicin and degradation products: rifampicin quinone and 3-formyl-rifampicin. Analysis was completed from a very small plasma volume (20 µL) using only protein precipitation with methanol. Chromatographic separation was achieved on a Kinetex Polar C18 column (2.6 µm; 150 × 3 mm) with a mobile phase consisting of 5 mM ammonium acetate and acetonitrile, both containing 0.1 % formic acid, in gradient elution. The analytes were detected using a positive ionization mode by multiple reaction monitoring. The LLOQ for RIF and its degradation products was 0.1 µg/mL, 0.05 µg/mL for INH, and 0.2 µg/mL for PZA. The method was validated based on the FDA guidance. The application of the method was confirmed in the analysis of RIF, INH, and PZA, as well as RIF metabolism/degradation products in plasma samples of patients with TB. Based on the detailed stability study of the analyzed compounds at various storage conditions, we proposed recommendations for handling the plasma and serum samples in TDM and other pharmacokinetic studies.
Collapse
Affiliation(s)
- Marta Karaźniewicz-Łada
- Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, Poznań 60-806, Poland; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA.
| | - Katarzyna Kosicka-Noworzyń
- Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, 3 Rokietnicka Street, Poznań 60-806, Poland; Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
| | - Prakruti Rao
- Division of Infectious Diseases and International Health, University of Virginia, 345 Crispell Drive, Charlottesville, VA, USA
| | - Nisha Modi
- Division of Infectious Diseases, Rutgers New Jersey Medical School, USA
| | - Yingda L Xie
- Division of Infectious Diseases, Rutgers New Jersey Medical School, USA
| | - Scott K Heysell
- Division of Infectious Diseases and International Health, University of Virginia, 345 Crispell Drive, Charlottesville, VA, USA
| | - Leonid Kagan
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA; Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, USA
| |
Collapse
|
3
|
Davuluri KS, Singh AK, Singh AV, Chaudhary P, Raman SK, Kushwaha S, Singh SV, Chauhan DS. Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas. Microbiol Spectr 2023; 11:e0319722. [PMID: 36719189 PMCID: PMC10100658 DOI: 10.1128/spectrum.03197-22] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2022] [Accepted: 11/05/2022] [Indexed: 02/01/2023] Open
Abstract
The majority of preclinical research has shown that Mycobacterium tuberculosis can modify host lipids in various ways. To boost its intramacrophage survival, M. tuberculosis causes host lipids to build up, resulting in the development of lipid-laden foam cells. M. tuberculosis binds to and enters the macrophage via the cell membrane cholesterol. Aggregation of cholesterol in the cell wall of M. tuberculosis and an increase in vascularity at the granuloma site reduce the permeability of rifampicin and isoniazid concentrations. However, very few studies have assessed the effect of statins on drug penetration. Here, we used atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, to observe its effect on the bacterial burden by increasing the drug concentration at the infection site. We looked into how atorvastatin could be used in conjunction with first-line drugs to promote drug permeation. In this study, we detected an accumulation of drugs at the peripheral sites of the lungs and impaired drug distribution to the diseased sites. The efficacy of antituberculosis drugs, with atorvastatin as an adjunct, on the viability of M. tuberculosis cells was demonstrated. A nontoxic statin dosage established phenotypic and normal granuloma vasculature and showed an additive effect with rifampicin and isoniazid. Our data show that statins help to reduce the tuberculosis bacterial burden. Our findings reveal that the bacterial load is connected with impaired drug permeability resulting from lipid accumulation in the bacterial cell wall. Statin therapy combined with antituberculosis medications have the potential to improve treatment in tuberculosis patients. IMPORTANCE Mycobacterium tuberculosis binds to and enters the macrophage via the cell membrane cholesterol. M. tuberculosis limits phagosomal maturation and activation without engaging in phagocytosis. Aggregation of cholesterol in the cell wall of M. tuberculosis and an increase in the vascularity at the granuloma site reduce the permeability of rifampicin and isoniazid concentrations. However, very few studies have assessed the effect of statins on drug penetration, which can be increased through a reduction in cholesterol and vascularity. Herein, we used atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, to observe its effect on bacterial burden through increasing the drug concentration at the infection site. Our main research goal is to diminish mycobacterial dissemination and attenuate bacterial growth by increasing drug permeability.
Collapse
Affiliation(s)
- Kusuma Sai Davuluri
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| | - Amit Kumar Singh
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| | - Ajay Vir Singh
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| | - Pooja Chaudhary
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| | - Sunil Kumar Raman
- Division of Pharmaceutics and Pharmacokinetics, CSIR, Central Drug Research Institute, Lucknow, India
| | - Shweta Kushwaha
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| | | | - Devendra Singh Chauhan
- Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India
| |
Collapse
|
4
|
Dual Drug Loaded pH-sensitive Micelles for Efficient Bacterial Infection Treatment. Pharm Res 2022; 39:1165-1180. [DOI: 10.1007/s11095-022-03182-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2021] [Accepted: 01/26/2022] [Indexed: 12/20/2022]
|
5
|
Kotadiya RM, Patel FN. Analytical Methods Practiced to Quantitation of Rifampicin: A Captious Survey. CURR PHARM ANAL 2021. [DOI: 10.2174/1573412916999200704144231] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:Rifampicin (RIF), also known as rifampin, a bactericidal antibiotic having
broad antibacterial activity against various gram-positive and gram-negative bacteria acts by inhibiting
DNA dependent RNA polymerase. RIF has been administered in different dosage forms like tablets,
capsules, injections, oral suspension, powder, etc. for the treatment of several types of bacterial infections,
including tuberculosis, Mycobacterium avium complex, leprosy and Legionnaires’ disease.
Introduction: To ensure the quality, efficacy, safety and effectiveness of RIF drug product, effective
and reliable analytical methods are of utmost importance. To quantify RIF for quality control or pharmacokinetic
purposes, alternative analytical methods have been developed along with the official compendial
methods.
Methods:In this review paper, an extensive literature survey was conducted to gather information on
various analytical instrumental methods used so far for RIF.
Results:These methods were high-performance liquid chromatography (42%), hyphenated techniques
(18%), spectroscopy (15%), high-performance thin-layer chromatography or thin-layer chromatography
(7%) and miscellaneous (18%).
Conclusion:All these methods were selective and specific for the RIF analysis.
Collapse
Affiliation(s)
- Rajendra Muljibhai Kotadiya
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Dist. Anand, Gujarat,India
| | - Foram Narottambhai Patel
- Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa, Dist. Anand, Gujarat,India
| |
Collapse
|
6
|
First Screen-Printed Sensor (Electrochemically Activated Screen-Printed Boron-Doped Diamond Electrode) for Quantitative Determination of Rifampicin by Adsorptive Stripping Voltammetry. MATERIALS 2021; 14:ma14154231. [PMID: 34361425 PMCID: PMC8347414 DOI: 10.3390/ma14154231] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/23/2021] [Revised: 07/23/2021] [Accepted: 07/26/2021] [Indexed: 01/28/2023]
Abstract
In this paper, a screen-printed boron-doped electrode (aSPBDDE) was subjected to electrochemical activation by cyclic voltammetry (CV) in 0.1 M NaOH and the response to rifampicin (RIF) oxidation was used as a testing probe. Changes in surface morphology and electrochemical behaviour of RIF before and after the electrochemical activation of SPBDDE were studied by scanning electron microscopy (SEM), CV and electrochemical impedance spectroscopy (EIS). The increase in number and size of pores in the modifier layer and reduction of charge transfer residence were likely responsible for electrochemical improvement of the analytical signal from RIF at the SPBDDE. Quantitative analysis of RIF by using differential pulse adsorptive stripping voltammetry in 0.1 mol L−1 solution of PBS of pH 3.0 ± 0.1 at the aSPBDDE was carried out. Using optimized conditions (Eacc of −0.45 V, tacc of 120 s, ΔEA of 150 mV, ν of 100 mV s−1 and tm of 5 ms), the RIF peak current increased linearly with the concentration in the four ranges: 0.002–0.02, 0.02–0.2, 0.2–2.0, and 2.0–20.0 nM. The limits of detection and quantification were calculated at 0.22 and 0.73 pM. The aSPBDDE showed satisfactory repeatability, reproducibility, and selectivity towards potential interferences. The applicability of the aSPBDDE for control analysis of RIF was demonstrated using river water samples and certified reference material of bovine urine.
Collapse
|
7
|
Kul D. Electrochemical Determination of Rifampicin Based on Its Oxidation Using Multi-Walled Carbon Nanotube-Modified Glassy Carbon Electrodes. Turk J Pharm Sci 2020; 17:398-407. [PMID: 32939135 DOI: 10.4274/tjps.galenos.2019.33600] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2019] [Accepted: 06/20/2019] [Indexed: 12/01/2022]
Abstract
OBJECTIVES The aim of the study was to investigate the electrochemical behavior of rifampicin (RIF) in the anodic direction using multi-walled carbon nanotube (MWCNT)-modified glassy carbon electrodes. MATERIALS AND METHODS The anodic investigation of RIF was carried out with cyclic, differential pulse, and square wave voltammetry. A three-electrode system consisting of a glassy carbon electrode with a modification by MWCNTs as the working electrode, a platinum wire as the counter electrode, and an Ag/AgCl electrode as reference was used for the experiments. RESULTS The anodic process of RIF was irreversible and diffusion controlled. Linear responses were obtained between 0.04 and 10 μM for both techniques in acetate buffer (pH 3.5) as supporting electrolyte. The limit of detection values were 7.51 and 11.3 nM for differential pulse and square wave voltammetry, respectively. The repeatability, reproducibility, precision, and accuracy of the proposed methods were also investigated. Determination of RIF was carried out on its pharmaceutical dosage forms and the results were compared with those from other electrochemical sensors and the liquid chromatographic and spectrophotometric methods in the literature. CONCLUSION These validated techniques provided selective, rapid, sensitive, precise, and cheap determination of RIF as alternative techniques to the liquid chromatographic and spectrophotometric methods in therapeutic drug monitoring.
Collapse
Affiliation(s)
- Dilek Kul
- Karadeniz Technical University Faculty of Pharmacy, Department of Analytical Chemistry, Trabzon, Turkey
| |
Collapse
|
8
|
Quantification of rifampicin and rifabutin in plasma of tuberculosis patients by micellar liquid chromatography. Microchem J 2020. [DOI: 10.1016/j.microc.2020.104865] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
9
|
van den Elsen SH, Akkerman OW, Wessels M, Jongedijk EM, Ghimire S, van der Werf TS, Bolhuis MS, Touw DJ, Alffenaar JWC. Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid. Eur Respir J 2020; 56:13993003.00803-2020. [DOI: 10.1183/13993003.00803-2020] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2020] [Accepted: 05/05/2020] [Indexed: 11/05/2022]
|
10
|
Yan Y, Ma J, Bo X, Guo L. Rod-like Co based metal-organic framework embedded into mesoporous carbon composite modified glassy carbon electrode for effective detection of pyrazinamide and isonicotinyl hydrazide in biological samples. Talanta 2019; 205:120138. [PMID: 31450409 DOI: 10.1016/j.talanta.2019.120138] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Revised: 07/01/2019] [Accepted: 07/08/2019] [Indexed: 02/07/2023]
Abstract
Herein, we report a novel composite fabricated via embedding rod-like Co based metal-organic framework (Co-MOF-74) crystals into MC matrix for the first time. The introduction of MC astricts the size of Co-MOF-74 crystals, enlarges the pore size and improves the electrical conductivity, which lead to the good electrochemical properties of the composite. The fabricated sensor based on Co-MOF-74@MC exhibits superior electrocatalytic activity toward the reduction of pyrazinamide (PZA) and the oxidation of isonicotinyl hydrazide (INZ). Under optimized conditions, the sensor shows two linear ranges from 0.3 to 46.5 μM and 46.5-166.5 μM with a high sensitivity of 7.2 μA μM-1 cm-2 and a detection limit of 0.21 μM for the determination of PZA. The electroanalytical sensing of INZ also gives two linear ranges of 0.15-1.55 μM and 1.55-592.55 μM with a detection limit of 0.094 μM. The mechanism involved was also discussed, briefly. The sensor is assessed toward the detection of PZA and INZ in human serum and urine samples. Recovery values varied from 97.08 to 103.20% for PZA sensing and 96.67-102.90% for INZ sensing, revealing the promising practicality of sensor for PZA and INZ detection.
Collapse
Affiliation(s)
- Yu Yan
- Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Faculty of Chemistry, Northeast Normal University, Changchun, 130024, PR China
| | - Jicheng Ma
- Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Faculty of Chemistry, Northeast Normal University, Changchun, 130024, PR China.
| | - Xiangjie Bo
- Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Faculty of Chemistry, Northeast Normal University, Changchun, 130024, PR China
| | - Liping Guo
- Key Laboratory of Nanobiosensing and Nanobioanalysis at Universities of Jilin Province, Faculty of Chemistry, Northeast Normal University, Changchun, 130024, PR China.
| |
Collapse
|
11
|
Peng J, Huang Q, Liu Y, Liu F, Zhang C, Huang Y, Huang W. The synthesis of graphene oxide covalently linked with nickel tetraamino phthalocyanine: A photoelectrochemical sensor for the analysis of rifampicin irradiated with blue light. J CHIN CHEM SOC-TAIP 2019. [DOI: 10.1002/jccs.201800451] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jinyun Peng
- College of Chemistry and Chemical EngineeringGuangxi Normal University for Nationalities Chongzuo China
- School of PharmacyHenan University of Traditional Chinese Medicine Zhengzhou China
| | - Qing Huang
- School of PharmacyHenan University of Traditional Chinese Medicine Zhengzhou China
| | - Yuxia Liu
- College of Physics and Electronic EngineeringGuangxi Normal University for Nationalities Chongzuo China
| | - Fengping Liu
- College of Chemistry and Chemical EngineeringGuangxi Normal University for Nationalities Chongzuo China
| | - Cuizhong Zhang
- College of Chemistry and Chemical EngineeringGuangxi Normal University for Nationalities Chongzuo China
| | - Yingying Huang
- College of Chemistry and Chemical EngineeringGuangxi Normal University for Nationalities Chongzuo China
| | - Wei Huang
- College of Chemistry and Chemical EngineeringGuangxi Normal University for Nationalities Chongzuo China
| |
Collapse
|
12
|
Stability studies of rifampicin in plasma and urine of tuberculosis patients according to the European Medicines Agency Guidelines. Bioanalysis 2019; 11:713-726. [PMID: 30994011 DOI: 10.4155/bio-2018-0174] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Aim: The macrolide antibiotic rifampicin is prescribed against several infections, like tuberculosis disease. This drug decays to rifampicin quinone. Results/methodology: The biological fluids were diluted in a micellar solution and directly injected. Using a C18 column and a mobile phase of 0.15 M SDS-6% 1-pentanol phosphate-buffered at pH 7, running at 1 ml/min, the analytes were resolved in less than 15 min. The detection was by absorbance at 337 nm. Method was validated by the guidelines of the European Medicines Agency. Decomposition of rifampicin to rifampicin quinone was also studied. Discussion/conclusion: Procedure is rapid, easy-to-handle, economic, eco-friendly and with a high sample throughput. It was successfully used to monitor rifampicin in the plasma and urine of tubercular patients.
Collapse
|
13
|
Fast and Simple LC-MS/MS Method for Rifampicin Quantification in Human Plasma. Int J Anal Chem 2019; 2019:4848236. [PMID: 30853987 PMCID: PMC6377990 DOI: 10.1155/2019/4848236] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2018] [Revised: 12/28/2018] [Accepted: 01/08/2019] [Indexed: 12/04/2022] Open
Abstract
A simple, fast, and cost-effective LC-MS/MS method for quantification of rifampicin in human plasma was developed and fully validated. The plasma samples containing rifampicin and isotopically labelled internal standard rifampicin D8, were cleaned up using a Captiva ND Lipids filtration plate. Chromatographic separation was achieved on an 1290 Infinity liquid chromatograph coupled to 6460 Triple Quadrupole operated in positive mode on a core-shell Kinetex C18 column (50 × 2.1 mm, 2.6 μm) by gradient elution using 0.1% formic acid in water and acetonitrile as a mobile phase. The proposed method is the fastest method published by now, both in terms of sample preparation (approximately one minute per sample) and chromatographic analysis (total run time 2.4 min). Another key benefit is the outstanding sensitivity and wide analytical range (5-40000 μg/L) with good linearity, accuracy, and precision. The method showed almost complete recovery (92%) and absence of any significant matrix effect as demonstrated by uniform responses from QC samples prepared in blood plasma from 6 volunteers (RSD <5%). The proposed method was successfully applied to rifampicin quantification in 340 patients' plasma samples, thus demonstrating its suitability for both therapeutic drug monitoring and pharmacokinetic analysis.
Collapse
|
14
|
Dehnavi A, Soleymanpour A. New chemically modified carbon paste sensor for nanomolar concentration measurement of rifampicin in biological and pharmaceutical media. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2019; 94:403-409. [DOI: 10.1016/j.msec.2018.09.052] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2018] [Revised: 07/31/2018] [Accepted: 09/19/2018] [Indexed: 10/28/2022]
|
15
|
Goutal S, Langer O, Auvity S, Andrieux K, Coulon C, Caillé F, Gervais P, Cisternino S, Declèves X, Tournier N. Intravenous infusion for the controlled exposure to the dual ABCB1 and ABCG2 inhibitor elacridar in nonhuman primates. Drug Deliv Transl Res 2018; 8:536-542. [PMID: 29294257 DOI: 10.1007/s13346-017-0472-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration. An intravenous infusion protocol would be preferred to achieve high and controlled plasma concentrations of elacridar in large animals, including nonhuman primates. Formulation of elacridar for i.v. infusion was achieved using a co-solvent strategy, resulting in an aqueous dispersion with a final concentration of 5 g L-1 elacridar with tetrahydrofuran (5% w/v) in aqueous D-glucose solution (2.5%, w/v). Particle size (mean = 2.8 ± 0.9 μm) remained stable for 150 min. The preparation was i.v. administered as a continuous infusion (12 mg kg-1 h-1 for 90 min) to three baboons. Arterial and venous plasma pharmacokinetics (PK) of elacridar were monitored using a newly developed and validated HPLC-UV method. Elacridar concentration increased rapidly to reach a plateau at 9.5 μg mL-1 within 20 min after the start of infusion. Elacridar PK in venous plasma did not differ from arterial plasma facing the BBB, indicating the absence of an arteriovenous concentration gradient. Intravenous infusion of elacridar allows for controlled exposure of the BBB and offers a useful tool to assess the impact of ABCB1/ABCG2 on drug disposition to the brain in nonhuman primates, a relevant animal model for the study of transporter function at the BBB.
Collapse
Affiliation(s)
- Sébastien Goutal
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France.,CEA/DRF/Institut de Biologie François Jacob/MIRCen, Fontenay-aux-Roses, France
| | - Oliver Langer
- Health and Environment Department, AIT Austrian Institute of Technology GmbH, Seibersdorf, Austria.,Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.,Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
| | - Sylvain Auvity
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France.,Variabilité de Réponse aux Psychotropes, INSERM, U1144, 75006, Paris, France.,Faculté de Pharmacie de Paris, Université Paris Descartes, Université Sorbonne Paris Cité, 75006, Paris, France
| | - Karine Andrieux
- Faculté de Pharmacie de Paris, Université Paris Descartes, Université Sorbonne Paris Cité, 75006, Paris, France.,UTCBS, CNRS UMR 8258, Inserm U1022, 75006, Paris, France
| | - Christine Coulon
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France
| | - Fabien Caillé
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France
| | - Philippe Gervais
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France
| | - Salvatore Cisternino
- Variabilité de Réponse aux Psychotropes, INSERM, U1144, 75006, Paris, France.,Faculté de Pharmacie de Paris, Université Paris Descartes, Université Sorbonne Paris Cité, 75006, Paris, France
| | - Xavier Declèves
- Variabilité de Réponse aux Psychotropes, INSERM, U1144, 75006, Paris, France.,Faculté de Pharmacie de Paris, Université Paris Descartes, Université Sorbonne Paris Cité, 75006, Paris, France
| | - Nicolas Tournier
- IMIV, CEA, Inserm, CNRS, Univ. Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France. .,CEA/DRF/JOLIOT/Service Hospitalier Frédéric Joliot, 91406, Orsay, France.
| |
Collapse
|
16
|
Novel electrochemical biosensor based on PVP capped CoFe 2 O 4 @CdSe core-shell nanoparticles modified electrode for ultra-trace level determination of rifampicin by square wave adsorptive stripping voltammetry. Biosens Bioelectron 2017; 92:509-516. [DOI: 10.1016/j.bios.2016.10.071] [Citation(s) in RCA: 54] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2016] [Revised: 10/09/2016] [Accepted: 10/25/2016] [Indexed: 11/21/2022]
|
17
|
Louveau B, Fernandez C, Zahr N, Sauvageon-Martre H, Maslanka P, Faure P, Mourah S, Goldwirt L. Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction. Biomed Chromatogr 2016; 30:2009-2015. [PMID: 27280327 DOI: 10.1002/bmc.3778] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2015] [Revised: 05/15/2016] [Accepted: 06/06/2016] [Indexed: 11/11/2022]
Abstract
A precise and accurate high-performance liquid chromatography (HPLC) quantification method of rifampicin in human plasma was developed and validated using ultraviolet detection after an automatized solid-phase extraction. The method was validated with respect to selectivity, extraction recovery, linearity, intra- and inter-day precision, accuracy, lower limit of quantification and stability. Chromatographic separation was performed on a Chromolith RP8 column using a mixture of 0.05 m acetate buffer pH 5.7-acetonitrile (35:65, v/v) as mobile phase. The compounds were detected at a wavelength of 335 nm with a lower limit of quantification of 0.05 mg/L in human plasma. Retention times for rifampicin and 6,7-dimethyl-2,3-di(2-pyridyl) quinoxaline used as internal standard were respectively 3.77 and 4.81 min. This robust and exact method was successfully applied in routine for therapeutic drug monitoring in patients treated with rifampicin.
Collapse
Affiliation(s)
- B Louveau
- AP-HP, Pharmacy Department, Saint-Louis Hospital, Paris, F-75010, France.,AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France
| | - C Fernandez
- AP-HP, Pharmacy Department, Saint-Louis Hospital, Paris, F-75010, France.,AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France
| | - N Zahr
- AP-HP, Pharmacology Department, Pitie-Salpetriere Hospital, Paris, F-75013, France
| | - H Sauvageon-Martre
- AP-HP, Pharmacy Department, Saint-Louis Hospital, Paris, F-75010, France.,AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France
| | - P Maslanka
- AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France
| | - P Faure
- AP-HP, Pharmacy Department, Saint-Louis Hospital, Paris, F-75010, France
| | - S Mourah
- AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France.,Université Paris Diderot, Sorbonne Paris Cité, Laboratoire de Pathologie, UMR-S 1165 and INSERM U976, F-75010, Paris, France
| | - L Goldwirt
- AP-HP, Pharmacology Department, Saint-Louis Hospital, Paris, F-75010, France
| |
Collapse
|